原文始发于微信公众号(药时代):足不出户,掌上学习FDA法规及注册事务!
S1C1:

https://class.drugtimes.cn/detail/v_5d8a4dd2a8d07_145ZPVLk/3
S1C2:
处方药产品提交IND
Prescription Drug Product Submissions – IND

https://class.drugtimes.cn/detail/v_5d8b07f9cafac_Cbv7RS3q/3
S1C3:
处方药产品提交NDA
Prescription Drug Product Submissions – NDA

https://class.drugtimes.cn/detail/v_5dba6f6e85372_Qhr7ztqs/3
S1C4:
药品提交:eCTD模块3
Drug Product Submissions – eCTD Module 3

https://class.drugtimes.cn/detail/v_5dba758642d5f_pMT1CBMl/3
S1C5:
伦理、专利、老药新用、仿制药
Ethics, Patents, Repurposing, Generics

https://class.drugtimes.cn/detail/v_5dba757c49c43_ejfqb2Iq/3
https://class.drugtimes.cn/detail/v_5dba7809cf732_6nPk5UqK/3
S2C1:
非临床药物测试
Nonclinical Drug Testing

https://class.drugtimes.cn/detail/v_5ddceff53edce_4t01t4Kk/3
S2C2:
良好实验室规范(GLP)的应用
Application of Good Laboratory Practices (GLPs)

https://class.drugtimes.cn/detail/v_5ddcf509f2bd2_ykzIiFBq/3
S2C3:
药品临床试验
Clinical Trials of Drug Products

https://class.drugtimes.cn/detail/v_5ddcf797db3a4_vdJjfGxC/3
S2C4:
良好临床规范(GCP)
Good Clinical Practices (GCPs)

https://class.drugtimes.cn/detail/v_5ddcfc33cd140_ChNILH6o/3
S2C5:
肿瘤药物临床试验
Oncology Clinical Trials
https://class.drugtimes.cn/detail/v_5ddcfdd9b89b6_v2cudYm8/3
S2C6:
临床试验统计学
Clinical Trial Statistics

https://class.drugtimes.cn/detail/v_5ddcfe2ea6a45_lkr3fMHK/3
S2C7:
化学、生产及控制(CMC)
Chemistry, Manufacturing and Controls

https://class.drugtimes.cn/detail/v_5ddcfe3235bf0_MhM5jghY/3
S3C1:
质量体系
Quality Systems

https://class.drugtimes.cn/detail/v_5e1d2f2ee8d46_EFObg4yL/3
S3C2:
批准后处方药的提交和合规性
Post-approval Prescription Drug Submissions and Compliance

https://class.drugtimes.cn/detail/v_5e1d3bd6c6664_CPxX4sNH/3
S3C3:
药物标签
Pharmaceutical Labeling

https://class.drugtimes.cn/detail/v_5e1d3bb195646_3Gg4VHrC/3
S3C4:
药物警戒
Pharmacovigilance

https://class.drugtimes.cn/detail/v_5e1d3bc4510c4_ZKJVgAaT/3
S3C5:
风险管理
Risk Management

https://class.drugtimes.cn/detail/v_5e1d556d523d1_XRJB7LYf/3
S3C6:
血液和血液制品
Blood and Blood Products

https://class.drugtimes.cn/detail/v_5e1d53c339955_hIJ4eqb8/3
https://class.drugtimes.cn/detail/v_5e1d547977a24_UIWKNkNg/3
S4C1:
生物药概述
Biologics Overview

https://class.drugtimes.cn/detail/v_5e1d5dcd9956d_no0M5zvN/3
S4C2:
生物药临床试验考虑要素
Biologic Clinical Considerations

https://class.drugtimes.cn/detail/v_5e1d606dbd45e_ZDpymHrC/3
S4C3:
生物类似药
Biosimilars

https://class.drugtimes.cn/detail/v_5e1d6064dd1fd_TRDzNOlR/3

上海市鼓励政策!
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权